ArticleDermatologic therapy2021

Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.

Khalaf Kridin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.